1Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom. 2Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom. Search for other ...

The progression-free survival of patients with HER2-positive metastatic breast cancer is significantly extended by a combination of two monoclonal antibodies, trastuzumab and pertuzumab, which target ...

cDepartment of Respiratory Medicine, Charing Cross Hospital, Imperial College Healthcare Trust, Fulham Palace Road, London, W6 8RF, UK dDepartment of Respiratory Medicine, University College London ...

aInstitute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen 518036, China bInstitute of Systems Biomedicine, Department of Pathology, School of Basic Medical Sciences, ...

KTH Royal Institute of Technology, Department of Chemistry, Division of Surface and Corrosion Science, 100 44 Stockholm, Sweden KTH Royal Institute of Technology, Department of Chemistry, Division of ...

Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte 28660, Spain ...

Fig. 2: Clonal haematopoiesis is a major source of cfDNA variants and molecular features distinguish clonal haematopoiesis-derived from tumour-derived cfDNA variants. In individuals that do not have a ...

Early detection of pancreatic cancer is challenging because cancer-specific symptoms occur only at an advanced stage, and a reliable screening tool to identify high-risk patients is lacking. To ...

In designing new nanoparticle drug delivery systems, it is critical to identify simple formulations that overcome multiple biological barriers while being safe, reproducible, and scalable. We modified ...

Primary lung cancer remains the leading cause of cancer-related death in the Western world, and the lung is a common site for recurrence of extrathoracic malignancies. Small-animal (rodent) models of ...